Intravesical Dimethyl Sulfoxide Inhibits Acute and Chronic Bladder Inflammation in Transgenic Experimental Autoimmune Cystitis Models

Intravesical Dimethyl Sulfoxide Inhibits Acute and Chronic Bladder Inflammation in Transgenic Experimental Autoimmune Cystitis Models

New animal models are greatly needed in interstitial cystitis/painful bladder syndrome (IC/PBS) research. We recently developed a novel transgenic cystitis model (URO-OVA mice) that mimics certain key aspects of IC/PBS pathophysiology. This paper aimed to determine whether URO-OVA cystitis model was...

Full description

Bibliographic Details
Main Authors:	Ronald Kim, Wujiang Liu, Xiaohong Chen, Karl J. Kreder, Yi Luo
Format:	Article
Language:	English
Published:	Hindawi Limited 2011-01-01
Series:	Journal of Biomedicine and Biotechnology
Online Access:	http://dx.doi.org/10.1155/2011/937061

Similar Items

Encrusted cystitis caused by corynebacterium urealyticum: a case report with novel treatment strategy of intravesical dimethyl sulfoxide
by: Tayyar Alp Ozkan, et al.

Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model
by: Ilker Fatih Sahiner, et al.

Interstitial cystitis - intravesical treatment
by: Fernando Gonçalves de Almeida, et al.
Published: (2019-05-01)

Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis
by: Roberto Soler, et al.
Published: (2008-08-01)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
by: Jing-Liang Chen, et al.
Published: (2020-02-01)

CYSTITIS CYSTICA – CHRONIC URINARY BLADDER INFLAMMATION IN CHILDREN
by: Magdalena Szymanek-Szwed, et al.
Published: (2021-02-01)

Chemical cystitis developed in experimental animals model: Topical effect of intravesical ozone application to bladder
by: Omer Bayrak, et al.
Published: (2014-01-01)

Intravesical Treatments and Predictors of Symptom Severity in Patients with Refractory Interstitial Cystitis/Painful Bladder Syndrome
by: Chung-Hsin Peng, et al.
Published: (2010)

Role of inflammation in bladder function and interstitial cystitis
by: Sonal Grover, et al.
Published: (2011-02-01)

The change of ultrastructure bladder urothelium ultrastructure in recurrent bacterial cystitis with intravesical injections of platelet-rich plasma
by: C.H. Chiang, et al.
Published: (2020-07-01)

Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome
by: Wei-Ching Lee, et al.
Published: (2011-10-01)

Pretreatment Features to Influence Effectiveness of Intravesical Hyaluronic Acid Instillation in Refractory Interstitial Cystitis/Painful Bladder Syndrome
by: Aram Kim, et al.
Published: (2014-09-01)

MIF mediates bladder pain, not inflammation, in cyclophosphamide cystitis
by: Fei Ma, et al.
Published: (2019-03-01)

Intravesical Bacillus Calmette-Guerin for Treatment of Refractory Interstitial Cystitis
by: Saeed Arasteh, et al.
Published: (2007-02-01)

A Pilot Study on Intravesical Administration of Curcumin for Cystitis Glandularis
by: Qiong Lu, et al.
Published: (2013-01-01)

cis-Dichloridotetrakis(dimethyl sulfoxide-κO)chromium(III) chloride dimethyl sulfoxide monosolvate
by: Nada A. Al-Najjar, et al.
Published: (2013-07-01)

The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome
by: Yu-Chen Peng, et al.
Published: (2020-11-01)

Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study
by: Claudio Giberti, et al.
Published: (2013-08-01)

Botulinum Neurotoxin A Intravesical Injections in Interstitial Cystitis/Bladder Painful Syndrome: A Systematic Review with Meta-Analysis
by: Antonella Giannantoni, et al.
Published: (2019-08-01)

Therapeutic effects and predictive factors for successful intravesical hyaluronic acid instillation in patients with interstitial cystitis/bladder pain syndrome
by: Cheng-Ling Lee, et al.
Published: (2015-06-01)

Inflammation and Tissue Remodeling in the Bladder and Urethra in Feline Interstitial Cystitis
by: F. Aura Kullmann, et al.
Published: (2018-04-01)

Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
by: Yuh-Chen Kuo, et al.
Published: (2016-03-01)

Intravesical hyaluronic acid treatment for ketamine-associated cystitis: Preliminary results
by: En Meng, et al.
Published: (2015-09-01)

Intravesical immunotherapy in nonmuscle invasive bladder cancer
by: Jan-Friedrich Jokisch, et al.
Published: (2015-01-01)

Biodegradation of Dimethyl-Sulfoxide from Wastewater
by: Hsin-Yi Ho, et al.
Published: (2013)

Electrogenerated chemiluminescence of violanthrone in dimethyl sulfoxide
by: K. Hansongnern, et al.
Published: (1999-01-01)

Detrusor myocyte autophagy protects the bladder function via inhibiting the inflammation in cyclophosphamide-induced cystitis in rats.
by: Jiang Zhao, et al.
Published: (2015-01-01)

Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
by: Xu Wang, et al.
Published: (2016-01-01)

Reduction of Protein Bound Methionine Sulfoxide by a Periplasmic Dimethyl Sulfoxide Reductase
by: Lionel Tarrago, et al.
Published: (2020-07-01)

Inflammation and central pain sensitization in Interstitial Cystitis/Bladder Pain Syndrome
by: Schrepf, Andrew David
Published: (2015)

Corrigendum: Inflammation and Tissue Remodeling in the Bladder and Urethra in Feline Interstitial Cystitis
by: F. Aura Kullmann, et al.
Published: (2018-11-01)

Inflammation and enhanced nociceptive responses to bladder distension produced by intravesical zymosan in the rat
by: Cannon Ronda, et al.
Published: (2006-02-01)

Uroplakin peptide-specific autoimmunity initiates interstitial cystitis/painful bladder syndrome in mice.
by: Kenan Izgi, et al.
Published: (2013-01-01)

A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis
by: Manuela Tutolo, et al.

Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome
by: Hsiu-Jen Wang, et al.
Published: (2019-11-01)

Systematic Review and Meta-Analysis of Intravesical Hyaluronic Acid and Hyaluronic Acid/Chondroitin Sulfate Instillation for Interstitial Cystitis/Painful Bladder Syndrome
by: Jung-Soo Pyo, et al.
Published: (2016-09-01)

Effects of Combination Treatment of Intravesical Resiniferatoxin Instillation and Hydrodistention in Patients with Refractory Painful Bladder Syndrome/Interstitial Cystitis: A Pilot Study
by: Byeong Kuk Ham, et al.
Published: (2012-03-01)

Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: a contemporary evaluation
by: Mary E. Westerman, et al.

The Early Histological Effects of Intravesical Instillation of Platelet-Rich Plasma in Cystitis Models
by: M. İrfan Dönmez, et al.
Published: (2016-09-01)

Dimethyl sulfoxide improves sensitivity and specificity of RT-PCR and qRT-PCR amplification of low-expressed transgenes
by: Trifunović Milana, et al.
Published: (2012-01-01)